Cargando…
Impact of Buzhong Yiqi Prescription on the Gut Microbiota of Patients with Obesity Manifesting Polycystic Ovarian Syndrome
Gut microbiota disorders are closely related to polycystic ovarian syndrome (PCOS). Buzhong Yiqi prescription (BZYQ) has a significant clinical effect on the treatment of patients with obesity exhibiting PCOS and phlegm-dampness syndrome caused by spleen deficiency (SPSD). Hence, this study aimed to...
Autores principales: | Ni, Zhexin, Cheng, Wen, Ding, Jie, Yao, Ruipin, Zhang, Danying, Zhai, Dongxia, Zhou, Ling, Yu, Chaoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984899/ https://www.ncbi.nlm.nih.gov/pubmed/33790981 http://dx.doi.org/10.1155/2021/6671367 |
Ejemplares similares
-
The protective effect of Buzhong Yiqi decoction on ischemic stroke mice and the mechanism of gut microbiota
por: Li, Qianqian, et al.
Publicado: (2022) -
Past and present: a bibliometric study on polycystic ovary syndrome
por: Cai, Mengcheng, et al.
Publicado: (2023) -
Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
por: Zhou, Ling, et al.
Publicado: (2020) -
Efficacy of Yougui pill combined with Buzhong Yiqi decoction in alleviating the sexual dysfunction in female rats through modulation of the gut microbiota
por: Wang, Yangyun, et al.
Publicado: (2021) -
Modified Buzhong Yiqi decoction for myasthenia gravis: A systematic review protocol
por: Jiang, Xiaotao, et al.
Publicado: (2018)